Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



PERRY MARK L Create: Alert

All | News | Filings
Date FiledTypeDescription
05/31/2023 4 PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP
Txns: Gifted 2,000 shares @ $0
Gifted 1,000 shares @ $0
Gifted 1,000 shares @ $0
02/28/2023 4 PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP
Txns: Sold 6,800 shares @ $235.3089, valued at $1.6M
Sold 6,100 shares @ $236.2549, valued at $1.4M
Sold 5,700 shares @ $237.3644, valued at $1.4M
Sold 1,400 shares @ $237.9968, valued at $333.2k
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/21/2022 4 PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP
Txns: Sold 1,800 shares @ $262.9, valued at $473.2k
Sold 12,100 shares @ $263.67, valued at $3.2M
Sold 2,716 shares @ $264.92, valued at $719.5k
Sold 100 shares @ $265.49, valued at $26.5k
06/21/2021 4 PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Exercised 3,037 restricted stock units @ $0
Granted 5,600 options to buy @ $37.09, valued at $207.7k
Granted 3,600 restricted stock units @ $0
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/19/2020 4 PERRY MARK L (Director) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 29,508 shares @ $0
Disposed/sold 21,800 options to buy @ $10, valued at $218k
Disposed/sold 11,000 options to buy @ $13.6, valued at $149.6k
Disposed/sold 11,000 options to buy @ $14, valued at $154k
Disposed/sold 11,000 options to buy @ $48.85, valued at $537.4k
Disposed/sold 6,600 options to buy @ $47.77, valued at $315.3k
Disposed/sold 3,000 options to buy @ $100.27, valued at $300.8k
06/23/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2020 4 PERRY MARK L (Director) has filed a Form 4 on MyoKardia, Inc.
Txns: Exercised 2,300 restricted stock units @ $0
06/12/2020 4 PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP
Txns: Granted 712 shares @ $0
05/29/2020 4 PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP
Txns: Sold 400 shares @ $326.5125, valued at $130.6k
Sold 802 shares @ $327.9323, valued at $263k
Sold 1,300 shares @ $329.2785, valued at $428.1k
Sold 1,600 shares @ $330.3163, valued at $528.5k
Sold 2,200 shares @ $331.3118, valued at $728.9k
Sold 1,100 shares @ $332.2009, valued at $365.4k
Sold 404 shares @ $333.4514, valued at $134.7k
Sold 1,202 shares @ $335.867, valued at $403.7k
Sold 800 shares @ $336.9725, valued at $269.6k
Sold 600 shares @ $338.0933, valued at $202.9k
Sold 600 shares @ $339.1567, valued at $203.5k
05/13/2020 4 PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Sold 2,633 shares @ $74.0088, valued at $194.9k
Sold 1,350 shares @ $75.4322, valued at $101.8k
Sold 600 shares @ $76.2842, valued at $45.8k
Sold 13,024 shares @ $77.7133, valued at $1M
Sold 34,698 shares @ $78.6481, valued at $2.7M
Sold 1,295 shares @ $79.1673, valued at $102.5k
Exercised 15,000 options to buy @ $20, valued at $300k
Exercised 8,600 options to buy @ $20, valued at $172k
Exercised 15,000 options to buy @ $18.85, valued at $282.8k
Exercised 15,000 options to buy @ $28.45, valued at $426.8k
02/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/20/2019 4 PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Granted 7,500 options to buy @ $56.3, valued at $422.3k
Granted 4,800 restricted stock units @ $0
06/17/2019 4 PERRY MARK L (Director) has filed a Form 4 on MyoKardia Inc
Txns: Granted 6,600 options to buy @ $47.17, valued at $311.3k
Granted 2,300 restricted stock units @ $0
05/28/2019 4 PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP
Txns: Granted 1,258 shares @ $0
06/22/2018 4 PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $42.25, valued at $633.8k
06/14/2018 4 PERRY MARK L (Director) has filed a Form 4 on MyoKardia Inc
Txns: Granted 11,000 options to buy @ $48.85, valued at $537.4k
05/21/2018 4 PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP
Txns: Granted 963 shares @ $0
02/13/2018 4 PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP
Txns: Sold 17,307 shares @ $227.9312, valued at $3.9M
08/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2017 4 PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $28.45, valued at $426.8k
06/16/2017 4 PERRY MARK L (Director) has filed a Form 4 on MyoKardia Inc
Txns: Granted 11,000 options to buy @ $14, valued at $154k
05/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
07/15/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/17/2016 4 PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
06/09/2016 4 PERRY MARK L (Director) has filed a Form 4 on MyoKardia Inc
05/23/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/22/2012 4 PERRY MARK L (Director) has filed a Form 4 on NVIDIA CORP
Txns: Granted 16,281 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy